Abstract
Schistosomes, like most other parasitic helminths, induce strong type-2 responses in which the Th2-cell defining cytokines (IL-4, -5, -6, -13 and others) are produced by Th cells and additional cell types such as basophils and eosinophils(1)–(3). Since mice are susceptible to infection with Schistosoma mansoni, one of the major schistosome parasites of humans, and develop a disease similar to human schistosomiasis, it has been possible to use this experimental host/parasite system to ask specific questions about the induction and function of the type 2 response during infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pearce, E. J., P. Caspar, J. M. Gryzch, F. A. Lewis, and A. Sher. 1991. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a helminth, Schistosoma mansoni. Journal of Experimental Medicine. 173:159–165.
Kullberg, M. C., J. A. Berzofsky, D. L. Jankovic, S. Barbieri, M. E. Williams, P. Perlmann, A. Sher, and M. Troye-Blomberg. 1996. T cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice. The Journal of Immunology. 156:1482–1490.
Sabin, E. A., M. A. Kopf, and E. J. Pearce. 1996. Schistosoma mansoni egg induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med. 184:1871–1878.
Pearce, E. J., and A. Sher. 1987. Mechanisms of immune evasion in schistosomiasis. In Contributions to Microbiology and Immunology; Antigenic variation: molecular and genetic mechanisms of relapsing disease. J. M. Cruse, and R. E. Lewis, editors. Karger, New York.
Bloch, E., M. Abdel-Wahab, and K. Warren. 1972. In vitro microscopic observation of the pathogenesis and pathophysiology of hepatosplenic schistosomiasis in the mouse liver. American Journal of Tropical Medicine and Hygiene. 21:546–557.
Mathew, R. C., and D. L. Boros. 1986. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced IL-2 production in Schistosoma mansoni infection. Infection and Immunity. 54:820–824.
Hernandez, H. J., Y. Wang, N. Tzellas, and M. J. Stadecker. 1997. Expression of class II, but not class i, makjor histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. European Journal of Immunology. 27:1170–1176.
Amiri, P., R. M. Locksley, T. G. Parslow, M. Sadick, E. Rector, D. Ritter, and J. H. McKerrow. 1992. Tumour necrosis factor a restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature. 356:604–606.
Doenhoff, M. J., R. Musallam, J. Bain, and A. McGregor. 1979. Schistosoma mansoni infection in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis. American Journal of Tropical Medicine and Hygiene. 28:260–273.
Dunne, D. W., F. M. jones, and M. J. Doenhoff. 1991. The purification, characterization, serological activity and hepatotoxic properties of two cationic glycoproteins from Schistosoma mansoni eggs. Parasitology. 103:225–236.
Velia, A. T., and E. J. Pearce. 1992. CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. Journal of Immunology. 148 (7):2283–2290.
Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol. 151:1430–40.
Coffman, R. L., and T. von der Weid. 1997. Multiple pathways for the initiation of T helper 2 (Th2) responses. Journal of Experimental Medicine. 185:373–375.
Sabin, E. A., and E. J. Pearce. 1995. Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. Journal of Immunology. 155(10):4844–4853.
Rincon, M., J. Anguita, T. Nakamura, E. Fikrig, and R. Flavell. 1997. Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4+ cells. Journal of Experimental Medicine. 185:461–469.
von der Weid, T., A. M. Beebe, D. C. Roopenian, and R. L. Coffman. 1996. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1-T cell population. Journal of Immunology. 157:4421–4427.
Cox, G., and J. Gauldie. 1997. Interleukin-6. In Cytokines in Health and Disease. D. Remick, and J. Friedland, editors. Marceli Dekker, New York.
Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature. 376:594–6.
Kaplan, M., J. Whitfield, D. Boros, and M. Grusby. 1998. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. Journal of Immunology. 160:1850–1856.
Rosa Brunet, L. R., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. Journal of Immunology. 159:777–785.
Cheever, A. W., M. E. Williams, T. A. Wynn, F. D. Finkelman, R. A. Seder, T. M. Cox, S. Hieny, P. Caspar, and A. Sher. 1994. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. Journal Immunology. 153 (2):753–9.
Metwali, A., D. Elliott, A. M. Blum, J. Li, M. Sandor, R. Lynch, N. Noben-Trauth, and J. V. Weinstock. 1996. The granulomatous response in murine schistosomiasis mansoni does not switch to Th1 in IL-4-defi-cient C57BL/6 mice. Journal of immunology. 157:4546–4553.
Beutler, B., V. Tkacenko, I. Milsark, N. Krochin, and A. Cerami. 1986. Effect of gamma-interferon on cachectin expression by mononuclear phagocytes: reversal of the lps d (endotoxin-resistant) phenotype. Journal of Experimental Medicine. 164:1791–1800.
Lyons, C. R. 1995. The role of nitric oxide in inflammation. Advances in Immunology. 60:323–371.
Bogdan, C., Y. Vodovotz, J. Paik, Q. Xie, and C. Nathan. 1994. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. Journal of Leukocyte Biology. 55:227–233.
Bogdan, C., H. Thuring, M. Dlaska, M. Rollinghoff, and G. Weiss. 1997. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. Journal of Immunology. 159:4506–4513.
Leist, M., F. Gantner, I. Bohlinger, G. Tiegs, R Germann, and A. Wendel. 1995. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. American Journal of Pathology. 146:1220–1234.
Leist, M., F. Gantner, G. Kunstle, I. Bohlinger, G. Tiegs, H. Bluethmann, and A. Wendel. 1996. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Molecular Medicine 2:109–124.
Young-Myeong, K., K. Tzeng, and T. Billiar. 1997. Role of NO and nitrogen intermediates in regulation of cell functions. In Nitric Oxide and the Kidney. Physiology and Pathophysiology. M. Gologorsky, and S. Gross, editors. Chapman and Hall, New York.
Bohlinger, I., M. Leist, J. Barsig, S. Uhlig, G. Tiegs, and A. Wendel. 1995. Tolerance against tumor necrosis factor alpha (TNF)-induced hepatotoxicity in mice: the role of nitric oxide. Toxicology Letters. 82–83:227.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pearce, E.J., La Flamme, A., Sabin, E., Brunet, L.R. (1998). The Initiation and Function of Th2 Responses during Infection with Schistosoma Mansoni . In: Gupta, S., Sher, A., Ahmed, R. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation VII. Advances in Experimental Medicine and Biology, vol 452. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5355-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5355-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7443-5
Online ISBN: 978-1-4615-5355-7
eBook Packages: Springer Book Archive